Gabapentin as a potential treatment for cough syncope

Respir Care. 2015 Feb;60(2):e34-7. doi: 10.4187/respcare.03255. Epub 2014 Aug 26.

Authors

Clara H K Wu¹, Keith Gunasekara², James H Hull³, Andras Bikov⁴, Adrian J Morris⁵, Omar S Usmani³

Affiliations

¹ Imperial College London, South Kensington Campus, London, United Kingdom. hkw09@imperial.ac.uk.
² Imperial College London, South Kensington Campus, London, United Kingdom.
³ Airway Diseases, National Heart and Lung Institute, Imperial College London and the Cough Clinic, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.
⁴ Department of Pulmonology, Semmelweis University, Budapest, Hungary.
⁵ William Harvey Hospital, Kent, United Kingdom.

PMID: 25161306
DOI: 10.4187/respcare.03255

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Amines / administration & dosage
Amines / therapeutic use*
Antitussive Agents / administration & dosage
Antitussive Agents / therapeutic use*
Chronic Disease
Cough / complications
Cough / drug therapy*
Cyclohexanecarboxylic Acids / administration & dosage
Cyclohexanecarboxylic Acids / therapeutic use*
Gabapentin
Humans
Male
Middle Aged
Syncope / drug therapy*
Syncope / etiology
gamma-Aminobutyric Acid / administration & dosage
gamma-Aminobutyric Acid / therapeutic use*

Substances

Amines
Antitussive Agents
Cyclohexanecarboxylic Acids
gamma-Aminobutyric Acid
Gabapentin

Grants and funding